Mariana Hainrichson

Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations

Igor Nudelman, Annie Rebibo-Sabbah, Marina Cherniavsky et al. · Journal of Medicinal Chemistry · 2009 · 184 citations · Full text

Premature Translational Termination, Genetics, Molecular Biology +20

Design, Synthesis, and Evaluation of Novel Fluoroquinolone−Aminoglycoside Hybrid Antibiotics

Varvara Pokrovskaya, Valery Belakhov, Mariana Hainrichson et al. · Journal of Medicinal Chemistry · 2009 · 135 citations

Characterization of a chemically modified plant cell culture expressed human α-Galactosidase-A enzyme for treatment of Fabry disease

Tali Kizhner, Yaniv Azulay, Mariana Hainrichson et al. · Molecular Genetics and Metabolism · 2014 · 126 citations · Full text

Glycobiology, Fabry Disease, Mannose Structures +16

Repairing faulty genes by aminoglycosides: Development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations

Igor Nudelman, Dana Glikin, Boris Smolkin et al. · Bioorganic & Medicinal Chemistry · 2010 · 123 citations

Diseases-causing Nonsense Mutations, Genetic Disorder, New Derivatives +7

Glycosylation and functionality of recombinant β-glucocerebrosidase from various production systems

Yoram Tekoah, Salit Tzaban, Tali Kizhner et al. · Bioscience Reports · 2013 · 96 citations · Full text

Recombinant β-Glucocerebrosidase, Engineering, Mannose Residues +20